Santa Cruz Biotechnology offers a broad range of Halotyrosine monoclonal antibodies for the detection and analysis of halotyrosine-modified proteins. Halotyrosine monoclonal antibodies are essential research tools in various applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Halotyrosine is a post-translational modification that can influence protein function and stability, playing a key role in cellular processes and disease mechanisms. The presence of halotyrosine serves as a biomarker for oxidative stress and has significant implications in neurodegenerative diseases and cancer research. Understanding halotyrosine modifications helps researchers uncover new pathways and potential therapeutic targets. Monitoring halotyrosine levels provides valuable information about cellular stress responses and protein modifications under various conditions. Advanced research techniques using halotyrosine monoclonal antibodies enable precise detection and quantification of modified proteins. Santa Cruz Biotechnology monoclonal antibodies for halotyrosine detection support researchers worldwide in advancing our understanding of cellular processes and disease mechanisms.